WELL Stock Analysis — Welltower
Sector: Healthcare REIT
AI Verdict
Welltower trades at 75.9x next year's earnings, so you're paying up for a narrative of explosive EPS growth that only holds if its scale-driven moat keeps out new entrants.
Competitive Moat
Welltower owns and operates a vast portfolio of senior housing and healthcare properties, benefiting from long-term demographic tailwinds as the population ages. Its scale and deep relationships with care operators create high barriers to entry for new competitors.
Summary
Welltower is notable for its aggressive EPS growth forecast of 42.3% next year, far outpacing typical REIT peers.
Where It Stands
Welltower is up 41.00% over the past year with an RSI of 37.1 signaling cooling momentum, but trades at 75.9x forward earnings—over three times the healthcare sector median of 22x.
Key Metrics
- RSI: 37.1 — Near Oversold
- Trailing P/E: 108.0x
- Forward P/E: 75.9x
- PEG Ratio: 2.56
- Earnings Growth: +0.4%
- Revenue Growth: +0.4%
- Market Cap: $170.8B
- Dividend Yield: 0.01%
- 1-Year Return: 41.00%
- 52-Week High: $255.20
- 52-Week Low: $161.26
Analyst Consensus
23 Buy · 5 Hold · 0 Sell (28 analysts)
Bull Case
Analysts expect 42.3% EPS growth next year, which partially justifies the premium 75.9x forward P/E if demographic trends continue to drive demand.
Bear Case
A pullback to the sector median P/E of 22x would mean a 71% valuation drop from current levels, with the 37.1 RSI suggesting further downside risk if growth disappoints.
Catalyst to Watch
Quarterly earnings and occupancy updates—if EPS growth falls short of the 42.3% target, the multiple could compress sharply.